A+ R A-

Incidence and Predisposition to WM

Please select from the following list of abstracts, representing the presentations given in Stockholm 2008 (IWWM-5) Session 1:

Trend and Geographic Variations in the Incidence of Waldenström s Macroglobulinemia in the United States over 17 Years from 1988 to 2004. Michael Wang, Yuhong Zhou, Haijun Wang, Qing Yi, Yanxia Zhang, Raymond Alexanian, Larry Kwak, Xin Du Lymphoma/Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA; Oncology, Fudan University, Shanghai, China; Epidemiology, University of Texas School of Public Health, Houston, TX, USA.

Prevalance of MGUS and Incidence of WM in Japan. Masako Iwanaga, M.D., M.P.H. Department of Molecular Medicine & Hematology, Atomic Bomb Disease Institute, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, JAPAN.

IgM Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Waldenström’s Macroglobulinemia (SWM) Robert A. Kyle, MD; Joanne T. Benson, BA; Dirk Larson, MS; Terry Therneau, PhD; Angela Dispenzieri, MD; Lee Joseph Melton III, MD; S. Vincent Rajkumar, MD Mayo Clinic, Rochester, MN, USA.

Familial Predisposition to Monoclonal Gammopathy of Unknown Significance, Waldenstrom's Macroglobulinemia and Multiple Myeloma. Helga M. Ögmundsdóttir, Helga K. Einarsdóttir, Hlíf Steingrímsdóttir, Vilhelmína Haraldsdóttir. Faculty of Medicine, University of Iceland; Department of Clinical Haematology, Landspitali Universtity Hospital, Reykjavik, ICELAND.

The relationship between Waldenström macroglobulinemia and IgM monoclonal gammopathy of undetermined significance: studies of high-risk families. Mary L. McMaster, Lynn Goldin, and Gyorgy Csako Genetic Epidemiology Branch, Human Genetics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Department of Health and Human Services, Bethesda, MD, USA.

Risk of lymphoproliferative disorders among first-degree relatives of lymphoplasmacytic lymphoma/Waldenström’s macroglobulinemia patients: A population-based study in Sweden. Sigurdur Y Kristinsson, Magnus Björkholm, Lynn R Goldin, Mary L McMaster, Ingemar Turesson, and Ola Landgren Department of Medicine, Division of Hematology, Karolinska University Hospital Solna and Karolinska Institutet, Stockholm, Sweden; National Cancer Institute, NIH, Bethesda, Maryland, USA; Department of Medicine, Section of Hematology, Malmö University Hospital, Malmö, SWEDEN.

Increased prevalence of monoclonal gammopathy, abnormal immunoglobulin levels, and recurrent infections in family members of patients with Familial Waldenström’s Macroglobulinemia. Z. R. Hunter, L. Ioakimidis, J. Soumerai, C. J. Patterson, L. Xu, X. Leleu, B. T. Ciccarelli, A. Sacco, S. Adamia, E. Hatjiharissi, S. P. Treon. Dana-Farber Cancer Institute, Boston, MA; Dana-Farber Cancer Institute, Boston, MA, USA. 

Stockholm 2008 (IWWM-5)

The 5th International Workshop on WM (IWWM-5) was made possible through the kind and generous unrestricted grants or gifts from the following sponsors:

Peter and Helen Bing Fund for Waldenström's Macroglobulinemia

 

Karen Lee Sobol Foundation

 

Bailey family Foundation for Waldenström's Macroglobulinemia

 

Linda and Edward Nelson Fund for Waldenström's Macroglobulinemia